InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,724.87
(
-1.03%
)
Post# of 4979500
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

conix

Send PM Follow Ignore
Followers 225
Posts 32268
Boards Moderated 3
Alias Born 10/10/2005

conix

Re: None

Sunday, 04/10/2022 12:54:19 PM

Sunday, April 10, 2022 12:54:19 PM

Post# of 4979500
This CUBT story has taken longer to unfold than I expected, BB, but their recent news about the clinical trials being paid for by the National Institutes of Health in the midst of a quiet period is, imo, significant.

There is good data on metformin and macular degeneration.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079568/

The NIH is doing trials on CUBT's eye drop formulation of metformin--not an oral dose.

I have been buying in 40k to 50 k increments as I sell other positions.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up